Sector Gamma AS’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $50.2M | Buy |
827,901
+81,946
| +11% | +$4.78M | 11.86% | 1 |
|
|
2025
Q4 | $40.2M | Buy |
745,955
+164,688
| +28% | +$7.92M | 9.17% | 1 |
|
|
2025
Q3 | $26.2M | Buy |
581,267
+175,267
| +43% | +$8.19M | 6.5% | 4 |
|
|
2025
Q2 | $18.8M | Sell |
406,000
-29,000
| -7% | -$1.42M | 6.14% | 3 |
|
|
2025
Q1 | $26.5M | Buy |
435,000
+68,834
| +19% | +$4.01M | 8.5% | 1 |
|
|
2024
Q4 | $20.7M | Sell |
366,166
-235,834
| -39% | -$13.2M | 7.12% | 3 |
|
|
2024
Q3 | $31.1M | Buy |
602,000
+67,000
| +13% | +$3.14M | 9.45% | 1 |
|
|
2024
Q2 | $22.2M | Buy |
535,000
+36,464
| +7% | +$1.63M | 8.3% | 3 |
|
|
2024
Q1 | $27M | Buy |
498,536
+123,849
| +33% | +$6.31M | 7.62% | 3 |
|
|
2023
Q4 | $19.2M | Sell |
374,687
-297,093
| -44% | -$15.6M | 4.66% | 6 |
|
|
2023
Q3 | $39M | Buy |
671,780
+164,204
| +32% | +$10.1M | 9.97% | 2 |
|
|
2023
Q2 | $32.5M | Buy |
507,576
+58,005
| +13% | +$3.89M | 7.26% | 3 |
|
|
2023
Q1 | $31.2M | Buy |
449,571
+71,902
| +19% | +$5.07M | 7.55% | 3 |
|
|
2022
Q4 | $27.2M | Buy |
377,669
+24,042
| +7% | +$1.81M | 6.21% | 4 |
|
|
2022
Q3 | $25.1M | Buy |
353,627
+41,931
| +13% | +$3.04M | 6.48% | 4 |
|
|
2022
Q2 | $24M | Sell |
311,696
-21,862
| -7% | -$1.67M | 5.37% | 5 |
|
|
2022
Q1 | $24.4M | Sell |
333,558
-15,033
| -4% | -$1.01M | 5.29% | 4 |
|
|
2021
Q4 | $21.7M | Sell |
348,591
-96,419
| -22% | -$5.66M | 5.11% | 4 |
|
|
2021
Q3 | $26.3M | Sell |
445,010
-78,483
| -15% | -$5.17M | 5.25% | 3 |
|
|
2021
Q2 | $35M | Buy |
523,493
+152,431
| +41% | +$9.94M | 6.2% | 4 |
|
|
2021
Q1 | $23.4M | Buy |
371,062
+9,719
| +3% | +$605K | 4.29% | 8 |
|
|
2020
Q4 | $22.4M | Sell |
361,343
-179,851
| -33% | -$11.1M | 4.27% | 8 |
|
|
2020
Q3 | $32.6M | Sell |
541,194
-103,339
| -16% | -$6.22M | 7.43% | 3 |
|
|
2020
Q2 | $37.9M | Sell |
644,533
-32,900
| -5% | -$1.97M | 7.82% | 1 |
|
|
2020
Q1 | $37.8M | Sell |
677,433
-288,000
| -30% | -$17.6M | 8.05% | 1 |
|
|
2019
Q4 | $62M | Sell |
965,433
-421,289
| -30% | -$24.1M | 9.93% | 1 |
|
|
2019
Q3 | $70.3M | Buy |
1,386,722
+35,000
| +3% | +$1.64M | 11.88% | 1 |
|
|
2019
Q2 | $61.3M | Sell |
1,351,722
-6,748
| -0.5% | -$314K | 9.85% | 1 |
|
|
2019
Q1 | $64.8M | Buy |
1,358,470
+230,000
| +20% | +$11.5M | 10.39% | 1 |
|
|
2018
Q4 | $58.7M | Buy |
1,128,470
+407,590
| +57% | +$21.9M | 9.86% | 2 |
|
|
2018
Q3 | $44.8M | Sell |
720,880
-181,346
| -20% | -$10.8M | 7.02% | 5 |
|
|
2018
Q2 | $49.9M | Buy |
902,226
+540,220
| +149% | +$29.2M | 8.3% | 4 |
|
|
2018
Q1 | $22.9M | Sell |
362,006
-23,000
| -6% | -$1.48M | 4.13% | 9 |
|
|
2017
Q4 | $23.6M | Sell |
385,006
-74,600
| -16% | -$4.67M | 3.97% | 10 |
|
|
2017
Q3 | $29.3M | Sell |
459,606
-429,784
| -48% | -$25.1M | 4.47% | 7 |
|
|
2017
Q2 | $49.6M | Buy |
889,390
+107,000
| +14% | +$5.82M | 7.2% | 3 |
|
|
2017
Q1 | $42.5M | Buy |
782,390
+333,100
| +74% | +$18.3M | 6.77% | 4 |
|
|
2016
Q4 | $26.3M | Sell |
449,290
-158,900
| -26% | -$8.69M | 4.94% | 7 |
|
|
2016
Q3 | $32M | Buy |
608,190
+420,690
| +224% | +$27M | 5.6% | 4 |
|
|
2016
Q2 | $13.8M | Sell |
187,500
-141,240
| -43% | -$9.98M | 2.62% | 19 |
|
|
2016
Q1 | $21M | Buy |
328,740
+116,250
| +55% | +$7.33M | 4.32% | 10 |
|
|
2015
Q4 | $14.6M | Sell |
212,490
-236,310
| -53% | -$15.6M | 3.76% | 12 |
|
|
2015
Q3 | $26.6M | Buy |
448,800
+169,400
| +61% | +$10.7M | 7.19% | 6 |
|
|
2015
Q2 | $18.6M | Buy |
279,400
+3,500
| +1% | +$231K | 4.75% | 7 |
|
|
2015
Q1 | $17.8M | Sell |
275,900
-109,300
| -28% | -$6.84M | 4.7% | 8 |
|
|
2014
Q4 | $22.7M | Buy |
385,200
+68,200
| +22% | +$3.85M | 5.06% | 5 |
|
|
2014
Q3 | $16.2M | Buy |
317,000
+207,000
| +188% | +$10.3M | 3.8% | 10 |
|
|
2014
Q2 | $5.34M | Buy |
+110,000
| New | +$5.42M | 1.26% | 24 |
|
Other funds holding BMY
VCM
VPM
Sector Gamma AS's BMY Position: Q1 2026 in Review
Sector Gamma AS increased its Bristol-Myers Squibb (BMY) stake by 11% in Q1 2026, buying an estimated $4.78M and bringing the position to 827,901 shares worth $50.2M. The position accounts for 11.86% of the portfolio, ranked #1.
Sector Gamma AS first reported a position in BMY in Q2 2014 and has held it in 48 quarters since. The position peaked at $70.3M in Q3 2019. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Sector Gamma AS held 827,901 shares of Bristol-Myers Squibb worth $50.2M as of Q1 2026.
- Sector Gamma AS bought 81,946 Bristol-Myers Squibb shares in Q1 2026, an estimated $4.78M.
- Bristol-Myers Squibb made up 11.86% of Sector Gamma AS's portfolio in Q1 2026, its #1 holding.
- Sector Gamma AS first reported a position in Bristol-Myers Squibb in Q2 2014 and has held it in 48 quarters since.
- Sector Gamma AS's Bristol-Myers Squibb position peaked at $70.3M in Q3 2019.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Sector Gamma AS's 13F filing for Q1 2026, filed 7 May 2026.